TY - JOUR
T1 - Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor
AU - Clark, Mary J.
AU - Emmerson, Paul J.
AU - Mansour, Alfred
AU - Akil, Huda
AU - Woods, James H.
AU - Portoghese, Philip S.
AU - Remmers, Ann E.
AU - Medzihradsky, Fedor
PY - 1997/11
Y1 - 1997/11
N2 - A C6 glioma cell line stably transfected with the rat delta opioid receptor (C6δ) was used to characterize receptor binding and G protein activation by both peptide and nonpeptide delta opioid ligands. The ligand binding affinities for [3H]naltrindole and [3H]pCl-[D-Pen2,D- Pen5]enkephalin (DPDPE) were similar to those observed in monkey brain membranes. The nonpeptide agonists, BW373U86 and SNC80, as well as peptide agonist [D-Ser2,L-Leu5]enkephalyl-Thr maximally stimulated [35S]GTPγS binding by 640, 654 and 576%, respectively, over basal. The peptide agonists, DPDPE and deltorphin II, both stimulated [35S]GTPγS binding by 375%. Etorphine, diprenorphine, oxymorphindole and 7-spiroindanyloxymorphone were also partial agonists in this assay, although they were less efficacious than deltorphin II. Stimulation of [35S]GTPγS binding by agonists was blocked completely by pertussis toxin pretreatment. Both delta-1 and delta-2 selective antagonists 7-benzylidenenaltrexone and a benzofuran analog of naltrindole displayed high affinity for the cloned receptor (0.04 and 0.08 nM) and antagonized the stimulation of [35S]GTPγS binding by BW373U86 and DPDPE with similar potencies. Other evidence suggesting the lack of receptor subtypes includes the finding that stimulation of [35S]GTPγS binding by receptor subtype selective ligands DPDPE and deltorphin II was not additive. BW373U86, SNC8O and DPDPE maximally inhibited forskolin-stimulated adenylyl cyclase. These cells highly express a homogeneous population of delta opioid receptor that couple to inhibitory G(o)/G(i) proteins. Ligand affinity for the delta opioid receptor correlates with ligand EC50 values for stimulation of [35S]GTPγS binding.
AB - A C6 glioma cell line stably transfected with the rat delta opioid receptor (C6δ) was used to characterize receptor binding and G protein activation by both peptide and nonpeptide delta opioid ligands. The ligand binding affinities for [3H]naltrindole and [3H]pCl-[D-Pen2,D- Pen5]enkephalin (DPDPE) were similar to those observed in monkey brain membranes. The nonpeptide agonists, BW373U86 and SNC80, as well as peptide agonist [D-Ser2,L-Leu5]enkephalyl-Thr maximally stimulated [35S]GTPγS binding by 640, 654 and 576%, respectively, over basal. The peptide agonists, DPDPE and deltorphin II, both stimulated [35S]GTPγS binding by 375%. Etorphine, diprenorphine, oxymorphindole and 7-spiroindanyloxymorphone were also partial agonists in this assay, although they were less efficacious than deltorphin II. Stimulation of [35S]GTPγS binding by agonists was blocked completely by pertussis toxin pretreatment. Both delta-1 and delta-2 selective antagonists 7-benzylidenenaltrexone and a benzofuran analog of naltrindole displayed high affinity for the cloned receptor (0.04 and 0.08 nM) and antagonized the stimulation of [35S]GTPγS binding by BW373U86 and DPDPE with similar potencies. Other evidence suggesting the lack of receptor subtypes includes the finding that stimulation of [35S]GTPγS binding by receptor subtype selective ligands DPDPE and deltorphin II was not additive. BW373U86, SNC8O and DPDPE maximally inhibited forskolin-stimulated adenylyl cyclase. These cells highly express a homogeneous population of delta opioid receptor that couple to inhibitory G(o)/G(i) proteins. Ligand affinity for the delta opioid receptor correlates with ligand EC50 values for stimulation of [35S]GTPγS binding.
UR - http://www.scopus.com/inward/record.url?scp=0030781511&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030781511&partnerID=8YFLogxK
M3 - Article
C2 - 9353363
AN - SCOPUS:0030781511
SN - 0022-3565
VL - 283
SP - 501
EP - 510
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 2
ER -